TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs
Qingyu Liao(Shanghai Jiao Tong University), Bianqin Guo(Chongqing University)
Cited by 27
Related Papers
PDK1‐stabilized LncRNA SPRY4‐IT1 promotes breast cancer progression via activating NF‐κB signaling pathway
|Molecular Carcinogenesis|2023|11
A simple and smart AND-gate DNA nanoprobe for correlated enzymes tracking and cell-selective imaging
|Biosensors and Bioelectronics|2022|10